138 related articles for article (PubMed ID: 24080714)
1. Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment: is it safe even in cancer patients?
Del Pup L; Di Francia R; Cavaliere C; Facchini G; Giorda G; De Paoli P; Berretta M
Anticancer Drugs; 2013 Nov; 24(10):989-98. PubMed ID: 24080714
[TBL] [Abstract][Full Text] [Related]
2. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
3. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
4. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
5. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
Simon JA; Maamari RV
Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
[TBL] [Abstract][Full Text] [Related]
7. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
[TBL] [Abstract][Full Text] [Related]
8. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
9. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
10. Recognizing and treating urogenital atrophy in postmenopausal women.
Goldstein I
J Womens Health (Larchmt); 2010 Mar; 19(3):425-32. PubMed ID: 20156082
[TBL] [Abstract][Full Text] [Related]
11. Local estrogen treatment in patients with urogenital symptoms.
Simunić V; Banović I; Ciglar S; Jeren L; Pavicić Baldani D; Sprem M
Int J Gynaecol Obstet; 2003 Aug; 82(2):187-97. PubMed ID: 12873780
[TBL] [Abstract][Full Text] [Related]
12. Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.
Santos I; Clissold S
Gynecol Endocrinol; 2010 Sep; 26(9):644-51. PubMed ID: 20374067
[TBL] [Abstract][Full Text] [Related]
13. Vaginal DHEA to treat menopause related atrophy: a review of the evidence.
Panjari M; Davis SR
Maturitas; 2011 Sep; 70(1):22-5. PubMed ID: 21733647
[TBL] [Abstract][Full Text] [Related]
14. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
Goldstein I; Alexander JL
J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy.
Palacios S; Ramirez M; Lilue M
Climacteric; 2022 Aug; 25(4):383-387. PubMed ID: 34813408
[TBL] [Abstract][Full Text] [Related]
16. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
[TBL] [Abstract][Full Text] [Related]
17. Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.
Santen RJ
Climacteric; 2015 Apr; 18(2):121-34. PubMed ID: 25327484
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy in postmenopausal women.
Yasui T; Uemura H; Takikawa M; Irahara M
J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
20. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
